Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Operating Leases (2019 - 2025)

Standard Biotools (LAB) has disclosed Operating Leases for 7 consecutive years, with $22.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases fell 21.9% to $22.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $22.0 million, a 21.9% decrease, with the full-year FY2024 number at $25.6 million, down 15.75% from a year prior.
  • Operating Leases was $22.0 million for Q3 2025 at Standard Biotools, down from $23.2 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $37.5 million in Q4 2021 to a low of $22.0 million in Q3 2025.
  • A 5-year average of $29.7 million and a median of $30.4 million in 2023 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: fell 1.65% in 2021, then dropped 21.9% in 2025.
  • Standard Biotools' Operating Leases stood at $37.5 million in 2021, then dropped by 9.23% to $34.1 million in 2022, then fell by 10.88% to $30.4 million in 2023, then fell by 15.75% to $25.6 million in 2024, then fell by 14.12% to $22.0 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Operating Leases are $22.0 million (Q3 2025), $23.2 million (Q2 2025), and $24.9 million (Q1 2025).